ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 51 • 2017 ACR/ARHP Annual Meeting

    Irisin Ameliorates Infrapatellar Adiposity in Knee Osteoarthritis Pathogenesis By Orchestrating Adipokine Signaling

    Feng-Sheng Wang1, Yi-Chih Sun1 and Jih-Yang Ko2, 1Core Facility for Phenomics & Diagnostics, Department of Medical Research, Core Facility for Phenomics & Diagnostics, Department of Medical Research, Kaohsiung Chang Gung Memorial Hospital, Taiwan, Kaohsiung, Taiwan, 2Department of Orthopedic Surgery, Department of Orthopedic Surgery, Kaohsiung Chang Gung Memorial Hospital, Taiwan, Kaohsiung, Taiwan

    Background/Purpose: Aberrant infrapatellar fat metabolism is a prominent feature that exacerbates inflammation and fibrosis relative to joint deterioration during osteoarthritis (OA). Irisin, a secretory subunit…
  • Abstract Number: 52 • 2017 ACR/ARHP Annual Meeting

    In Vivo Effect of Opticin Deficiency in a Surgically Induced Mouse Model of Osteoarthritis

    Aina Farran1, Gladys Valverde-Franco2, Laura Tio3, Bertrand Lussier4, Hassan Fahmi2, Jean-Pierre Pelletier2, Paul Bishop5, Jordi Monfort6 and Johanne Martel-Pelletier2, 1Osteoarthritis Research Unit (CRCHUM), Montreal; Inflammation and Cartilage Cellular Research Group, IMIM (Hospital del Mar Research Unit) Rheumatology Department, Parc de Salut Mar, Hospital del Mar, Barcelona, Barcelona, Spain, 2Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 3Inflammation and Cartilage Cellular Research Group, IMIM (Hospital del Mar Research Unit) Rheumatology Department, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain, 4Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM); Faculty of Veterinary Medicine, Clinical Sciences, University of Montreal, Sainte-Hyacinthe, QC, Canada, 5Manchester Royal Eye Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre; School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, 6Inflammation and Cartilage Cellular Research Group, IMIM (Hospital del Mar Research Unit) Rheumatology Department, Parc de Salut Mar; Rheumatology Department, Hospital del Mar, Barcelona, Spain

    Background/Purpose: Opticin (OPTC) is a small leucine-rich proteoglycan (SLRP) that has been previously demonstrated to be produced and degraded in osteoarthritic (OA) human cartilage. Here,…
  • Abstract Number: 53 • 2017 ACR/ARHP Annual Meeting

    Poly-γ-Glutamic Acid Inhibits RANKL- Induced Osteoclast Differentiation and Prevents Bone Destruction in Rheumatoid Arthritis: Human and CIA Mouse Model

    Bitnara Lee1, Jong-Dae Ji2 and Tae-Hwan Kim1, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 2Rheumatology, Korea University Hospital, Seoul, Korea, Republic of (South)

    Background/Purpose: Rheumatoid arthritis (RA) is an inflammatory disease that is characterized by chronic inflammation and bone destruction. Osteoclasts, which are bone-resorbing cells, are generally known…
  • Abstract Number: 54 • 2017 ACR/ARHP Annual Meeting

    Maintaining Angiogenesis Prevents Glucocorticoid Induced Osteonecrosis

    Alanna Dubrovsky1, Wei Yao1, Geetha Mohan1, Mie Jin Lim1, Yu-An Evan Lay1, Donald Kimmel2 and Nancy E. Lane3,4,5,6,7,8, 1UC Davis Center for Musculoskeletal Health, Sacramento, CA, 2Creighton University School of Medicine Osteoporosis Research Center, Omaha, NE, 3Center for Musculoskeletal Health, University of California, Davis School of Medicine, Sacramento, CA, 4Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, 5UC Davis Medical Center, Sacramento, CA, 6Center for Musculoskeletal Health, Univ of California at Davis, Sacramento, CA, 7Medicine, U.C. Davis, Sacramento, CA, 8UCDMC, Sacramento, CA

    Background/Purpose: Atraumatic osteonecrosis (ON) results from reduced bone vascularity. Glucocorticoids (GC) are a major risk factor for ON, as GCs reduce vascular endothelial growth factor,…
  • Abstract Number: 55 • 2017 ACR/ARHP Annual Meeting

    Nrf2 Inhibits Apoptosis and Suppresses Oxidative Stress By Activating NOX4/ERK1/2/ELK1 Signaling Axis in Human Chondrocytes

    Mohammad N. Khan1, Imran Ahmad1, Mohammad Y Ansari2 and Tariq M Haqqi1, 1Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH, 2Anatomy & Neurobiology, Northeast Ohio Medical University, Roostown, OH

    Background/Purpose: Nrf2 is a redox sensitive transcription factor that regulates the expression of phase II antioxidant enzymes and cytoprotective genes and is crucial for maintaining…
  • Abstract Number: 56 • 2017 ACR/ARHP Annual Meeting

    Baicalein, a Plant-Derived Small Molecule, Activate Nrf2/Autophagy Signaling Axis Via MEK1/2-ERK1/2-Elk1 Pathway to Suppress the Expression of IL-6 in Human Osteoarthritis Chondrocytes

    Mohammad N. Khan1, Imran Ahmad1, Mohammad Y. Ansari2 and Tariq M Haqqi1, 1Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH, 2Anatomy & Neurobiology, Northeast Ohio Medical University, Roostown, OH

    Background/Purpose: Inflammation is an important component of osteoarthritis (OA) pathogenesis. IL-6 is implicated in OA pathogenesis as it suppresses anabolic factors and upregulate the expression…
  • Abstract Number: 57 • 2017 ACR/ARHP Annual Meeting

    Accelerated Development of Aging-Associated and Instability-Induced Osteoarthritis in 12/15-Lipoxygenase Deficient Mice

    Lauris Habouri1, Yassine Ouhaddi1, Gadid Guedi1, Jean-Pierre Pelletier2, Johanne Martel-Pelletier2, mohamed benderdour1 and Hassan Fahmi2, 1Medicine, CRCHUM, Montreal, QC, Canada, 2Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada

    Background/Purpose: 12/15-Lipoxygenase (12/15-LOX) catalyzes the generation of various anti-inflammatory lipid mediators, and has been implicated in several inflammatory and degenerative diseases. However, there is currently…
  • Abstract Number: 58 • 2017 ACR/ARHP Annual Meeting

    Cartilage-like Tissue Generation By 3D-Bioprinting of Induced Pluripotent Stem Cells

    Rocío Castro-Viñuelas1, Alma Forsman2, Erdem Karabulut3, Erik Romberg3, Camilla Brantsing2, Mats Brittberg4, Anders Lindahl2, Paul Gatenholm3 and Stina Simonsson2, 1Cell Therapy and Regenerative Medicine research group. Rheumatology Division. Institute of Biomedical Research of A Coruña (INIBIC). Dep. of Biomedical Sciences, Medicine and Physiotherapy, University of A Coruña, A Coruña, Spain, 2Institute of Biomedicine at Sahlgrenska Academy, Department of Clinical Chemistry and Transfusion Medicine, University of Gothenburg., Gothenburg, Sweden, 33D Bioprinting Center, Dept. of Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, Sweden, 4Cartilage Repair Unit, University of Gothenburg, Region Halland Orthopaedics, Kungsbacka Hospital, Kungsbacka, Sweden

    Background/Purpose: Cartilage lesions due to traumatic or pathological conditions slowly grow over the time and may lead to osteoarthritis (OA). As a prospective treatment for…
  • Abstract Number: 59 • 2017 ACR/ARHP Annual Meeting

    Abaloparatide, a Novel PTHrP Analog, Increased Bone Mass and Density at Cortical and Trabecular Sites in an Orchiectomized Rat Model of Male Osteoporosis

    Heidi Chandler1 and Gary Hattersley2, 1Research, Radius Health Inc, Waltham, MA, 2Radius Health, Inc., Waltham, MA

    Background/Purpose: Male osteoporosis, a disease of reduced bone mass leading to an increased risk of fragility fractures, often results from androgen deficiency caused by hypogonadism…
  • Abstract Number: 60 • 2017 ACR/ARHP Annual Meeting

    Low and Moderate Intensity Exercise Suppresses Inflammatory Responses in an Acute Mouse Model of Gout and Suggests Therapeutic Efficacy

    Nicholas A. Young1, Kyle Jablonski2, Juhi Sharma1, Evelyn Thomas1, Brian Snoad1, Jeffrey Hampton3, Wael Jarjour1 and Naomi Schlesinger4, 1Department of Internal Medicine, Division of Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2The Ohio State University Wexner Medical Center, Columbus, OH, 3Immunology and Rheumatoloty, The Ohio State University Wexner Medical Center, Columbus, OH, 4Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ

    Background/Purpose: Little is known regarding the potential benefits of exercise on managing acute gout. Consequently, recent clinical practice guidelines released by the American College of…
  • Abstract Number: 61 • 2017 ACR/ARHP Annual Meeting

    Resolution of Systemic Joint Inflammatory Processes and Regeneration of Existing Bone Damage upon TNF Blockade As Monitored By In Vivo Multimodal PET-CT Imaging in Progressed Experimental Arthritis

    Silvia Hayer1, Markus Zeilinger2,3, Volker Weiss3,4, Markus Seibt5, Birgit Niederreiter1, Tetyana Shvets6, Monika Dumanic6, Florian Pichler6, Marcus Hacker6, Josef S. Smolen7, Kurt Redlich8 and Markus Mitterhauser6, 1Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Faulty of Engineering, University of Applied Sciences, Winer Neustadt, Austria, 3Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria, 4Faculty of Engineering, University of Applied Sciences, Wiener Neustadt, Austria, 5Department Internal Medicine III, Division Rheumatology, Medical University of Vienna, Vienna, Austria, 6Medical University of Vienna, Vienna, Austria, 7Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria, 8Division of Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: To use in vivo multimodal [18F]FDG (fluoro-D-glucose, tracer for inflammation) and [18F]Sodium Fluoride (bone tracer) positron emission tomography/computed tomography (PET-CT) imaging for the monitoring…
  • Abstract Number: 62 • 2017 ACR/ARHP Annual Meeting

    Convergence of Joint Repair and Pain Pathways Via Nerve Growth Factor and p75 Expressing Mesenchymal Stem Cells in Established Osteoarthritis

    Thomas Baboolal1, Sumaiya Al Hinai2, Elena Jones2, Jill Reckless3, Martyn Foster4, Rachel Doyle5, Kerry af Forselles4, Simon Westbrook4 and Dennis McGonagle2, 1PhD, Leeds, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Rxcelerate Ltd, Cambridge, United Kingdom, 4Levicept Ltd, Ramsgate, United Kingdom, 5Tetrad Discovery Ltd, Ramsgate, United Kingdom

    Background/Purpose: Nerve growth factor (NGF) is a key regulator of pain and anti-NGF therapy reduces osteoarthritis (OA) associated pain. However, anti-NGF therapy is associated with…
  • Abstract Number: 63 • 2017 ACR/ARHP Annual Meeting

    MiR-146a a Key Player in Bone Metabolism

    Victoria Saferding1, Melanie Hofmann1, Julia S. Brunner2, Antonia Puchner1, Melanie Timmen3, Richard Stange3, Josef S. Smolen4 and Stephan Blüml4, 1Medical University of Vienna, Austria, Vienna, Austria, 2Vascular Biology and Thrombosis research, Medical University of Vienna, Austria, Vienna, Austria, 3Institute for Experimental Muskuloskeletal Medicine, University Hospital Muenster, Muenster, Germany, 4Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria

    Background/Purpose: Micro RNAs (miRNAs) play a crucial role in the regulation of bone metabolism. MiR-146a, an important anti-inflammatory miRNA, was found to negatively impact osteogenesis…
  • Abstract Number: 64 • 2017 ACR/ARHP Annual Meeting

    The Effect of Adenosine A2A Receptor Stimulation on Mitochondrial Metabolism in the Pathogenesis and Treatment of Osteoarthritis

    Cristina Castro1, Carmen Corciulo2 and Bruce Cronstein3, 1Medicine, NYU School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 3Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, affecting nearly 10% of the US population. There is no therapy to prevent the progression…
  • Abstract Number: 65 • 2017 ACR/ARHP Annual Meeting

    RA-Associated Antibodies Targeting Post Translational Modification Have Different Osteoclastogenetic Potential

    Akilan Krishnamurthy1, Johanna Steen2, Caroline Grönwall3, Gustaf Wigerblad4, Camilla Svensson5,6, Heidi Wähämaa1, Vivianne Malmström1, Bence Rethi1 and Anca I. Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 3Dep. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 4Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 5Dept. of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden, 6Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Some but not all antibodies against citrullinated modified proteins (ACPA) promote osteoclastogenesis and bone destruction in vitro and in vivo. We aimed to investigate…
  • « Previous Page
  • 1
  • …
  • 1207
  • 1208
  • 1209
  • 1210
  • 1211
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology